Most patients with alopecia areata who had hair regrowth with baricitinib and discontinued maintenance therapy experienced a relapse of hair loss.

Prostaglandin analogues and phosphodiesterase inhibitors, either alone or as add-on therapy, are effective treatments for vitiligo repigmentation.

From 1990 to 2021, the burden of AMR decreased for those younger than 5 years and increased for those older than 70 years.

High levels of well-being may protect against the risks for cardiovascular diseases, according to study findings.

The FDA has accepted for filing the NDA for delgocitinib cream as a treatment for moderate to severe chronic hand eczema in adults.

Long COVID is common among veterans in the Airborne Hazards and Open Burn Pit Registry; however, the risk is not augmented by deployment exposures.

Patients with PsA who received bimekizumab demonstrated sustained improvements in clinical outcomes for up to 52 weeks, regardless of concomitant MTX use.

Policy interventions to mitigate heat-related illness are needed based on the relationship between high HVI and severe stroke.